South Korean drugmaker Celltrion Inc (068270.KS) aims to set up a joint venture in China within the first half of this year, and begin selling products in the country next year, its chairman said on Sunday. “Since last year, we’ve been pushing on with a plan to set up a joint venture in China,” Chai...
The post South Korea’s Celltrion aims to set up China venture within first half of 2019: chairman appeared first on Raw Story.
CONTINUE READING >>>